NextFin News - OpenAI has officially transitioned from an AI research lab to a commercial advertising entity with the launch of its first Ads Manager dashboard, a move that coincides with Google’s revelation that its health-related AI queries have hit a staggering one billion per day. The dual milestones, reached in the third week of March 2026, signal a fundamental shift in the digital economy: the "search" era is being cannibalized by "agentic" commerce, where conversational intent is the new gold standard for high-margin advertising.
The OpenAI Ads Manager, currently being tested with a select group of partners, represents the plumbing for a business model that CEO Sam Altman once described as a "last resort." According to Adweek, the dashboard allows marketers to run and monitor campaigns within ChatGPT, though the infrastructure remains in its infancy. Early participants are reportedly receiving weekly CSV reports rather than the real-time analytics suites offered by Meta or Google. Despite this technical lag, OpenAI is demanding a premium for entry, setting minimum advertiser commitments at $200,000 with CPMs (cost per thousand impressions) hovering around $60. For comparison, average CPMs on Meta often fall below $20, suggesting OpenAI is betting heavily on the superior conversion power of conversational context.
That bet may have some statistical backing. Data from Criteo, OpenAI’s first ad-tech partner, indicates that users referred by large language models (LLMs) convert at 1.5 times the rate of traditional referral channels. This efficiency is what OpenAI is counting on to reach its internal projections of $1 billion in ad revenue for 2026, scaling to $25 billion by 2029. However, the path to those billions is fraught with friction. Major holding companies like Publicis have recently advised clients to distance themselves from automated buying platforms like The Trade Desk over transparency concerns, a warning shot that OpenAI’s nascent "black box" ad system will eventually have to address.
While OpenAI builds its dashboard, Google is fortifying its moat through sheer scale and specialized utility. At "The Check Up 2026" event on March 17, Google’s Hema Budaraju confirmed the platform now processes one billion health queries daily. This is not merely a search statistic; it is an operational baseline for a new ecosystem of AI-driven wellness. Google is integrating medical records into Fitbit devices and deploying its AMIE diagnostic model in nationwide studies. By turning a billion daily questions into a conversational "AI Mode" interface, Google is effectively capturing the highest-value intent in the advertising world—healthcare—where pharmaceutical and insurance CPMs are historically the most lucrative.
The competition is no longer about who has the best index of the web, but who can provide the most reliable "agentic" response. Amazon has followed a similar trajectory, recently expanding its Health AI agent from the One Medical app to its main shopping interface. This multi-agent architecture can book appointments and interpret lab results, directly competing for the same billion queries Google currently dominates. The stakes are high: a Stanford study published earlier this year warned that AI medical models still produce clinical errors in 22% of cases. For advertisers, the risk of "hallucination" in a health context is a legal minefield that could temper the aggressive rollout of these conversational tools.
The industry is responding to this complexity through rapid consolidation in measurement. Smartly’s recent move to acquire INCRMNTAL, a marketing measurement firm using causal AI, highlights the desperate need for "always-on" incrementality testing. As OpenAI and Google move toward opaque, AI-driven ad delivery, marketers are searching for independent ways to prove that their $60 CPMs are actually driving new sales rather than just claiming credit for existing ones. The shift toward agentic AI has turned the digital ad market into a high-stakes laboratory where the price of entry is rising as fast as the technology itself.
Explore more exclusive insights at nextfin.ai.
